Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens
- PMID: 12965943
- DOI: 10.7326/0003-4819-139-5_part_1-200309020-00010
Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens
Abstract
Background: The development of antibodies to thyroid peroxidase, thyroglobulin, and thyroid-stimulating hormone (TSH) receptor is a main feature of autoimmune thyroid diseases.
Objective: To investigate whether complete removal of thyroid antigens results in the abatement of humoral thyroid autoimmunity.
Design: Retrospective chart review study of patients treated and monitored with a standard prospective protocol.
Setting: University hospital in Pisa, Italy, between 1976 and 1994.
Patients: 182 patients with differentiated thyroid carcinoma and serum antibodies to thyroid peroxidase, thyroglobulin, or TSH receptor due to coexistent clinical Hashimoto thyroiditis, Graves disease, or focal autoimmune thyroiditis.
Intervention: Total thyroidectomy and radioiodine treatment to ablate residual or metastatic thyroid tissue. Regular follow-up with iodine-131 whole-body scanning and serum thyroglobulin measurement. Mean follow-up (+/-SD) was 10.1 +/- 4.1 years (range, 4 to 20 years).
Measurements: Serum antibodies to thyroid peroxidase, thyroglobulin, and TSH receptor.
Results: Thyroid peroxidase, thyroglobulin, and TSH-receptor antibodies progressively disappeared after the initial treatment. The median disappearance time was 6.3 years for thyroid peroxidase antibodies and 3.0 years for thyroglobulin antibodies. There was a statistically significant correlation between the disappearance of thyroid tissue and that of thyroid antibodies. The coexistence of Hashimoto thyroiditis or Graves disease with thyroid cancer did not modify the pattern of disappearance of thyroid antibody compared with patients with focal autoimmune thyroiditis.
Conclusions: Complete ablation of thyroid tissue with its antigenic components results in the disappearance of antibodies to all major thyroid antigens, thus supporting the concept that continued antibody production depends on the persistence of autoantigen in the body.
Summary for patients in
-
Summaries for patients. Effects of removing thyroid antigens in patients with autoimmune thyroid disease.Ann Intern Med. 2003 Sep 2;139(5 Pt 1):I75. doi: 10.7326/0003-4819-139-5_part_1-200309020-00005. Ann Intern Med. 2003. PMID: 12965958 No abstract available.
Similar articles
-
Summaries for patients. Effects of removing thyroid antigens in patients with autoimmune thyroid disease.Ann Intern Med. 2003 Sep 2;139(5 Pt 1):I75. doi: 10.7326/0003-4819-139-5_part_1-200309020-00005. Ann Intern Med. 2003. PMID: 12965958 No abstract available.
-
Possible reasons for different pattern disappearance of thyroglobulin and thyroid peroxidase autoantibodies in patients with differentiated thyroid carcinoma following total thyroidectomy and iodine-131 ablation.J Endocrinol Invest. 2007 Mar;30(3):173-80. doi: 10.1007/BF03347421. J Endocrinol Invest. 2007. PMID: 17505148
-
[The role of hereditary and environmental factors in autoimmune thyroid diseases].Orv Hetil. 2012 Jul 1;153(26):1013-22. doi: 10.1556/OH.2012.29370. Orv Hetil. 2012. PMID: 22735372 Review. Hungarian.
-
Clinical and laboratory aspects of thyroid autoantibodies.Ann Clin Biochem. 2006 May;43(Pt 3):173-83. doi: 10.1258/000456306776865043. Ann Clin Biochem. 2006. PMID: 16704751 Review.
-
Thyroid autoantibodies.Endocrinol Metab Clin North Am. 2001 Jun;30(2):315-37, viii. doi: 10.1016/s0889-8529(05)70189-4. Endocrinol Metab Clin North Am. 2001. PMID: 11444165 Review.
Cited by
-
A Quantitative Evaluation of Hepatic Uptake on I-131 Whole-Body Scintigraphy for Postablative Therapy of Thyroid Carcinoma.Medicine (Baltimore). 2015 Jul;94(28):e1191. doi: 10.1097/MD.0000000000001191. Medicine (Baltimore). 2015. PMID: 26181567 Free PMC article.
-
Effectiveness of radioiodine (131-I) as definitive therapy in patients with autoimmune and non-autoimmune hyperthyroidism.J Endocrinol Invest. 2006 Jul-Aug;29(7):594-8. doi: 10.1007/BF03344157. J Endocrinol Invest. 2006. PMID: 16957406
-
Definition of the upper reference limit for thyroglobulin antibodies according to the National Academy of Clinical Biochemistry guidelines: comparison of eleven different automated methods.Auto Immun Highlights. 2017 Dec;8(1):8. doi: 10.1007/s13317-017-0096-3. Epub 2017 Jun 19. Auto Immun Highlights. 2017. PMID: 28631225 Free PMC article.
-
Persistent symptoms in euthyroid Hashimoto's thyroiditis: current hypotheses and emerging management strategies.Front Endocrinol (Lausanne). 2025 Jul 18;16:1627787. doi: 10.3389/fendo.2025.1627787. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40756512 Free PMC article. Review.
-
Total thyroidectomy in Basedow-Graves' disease treatment: our experience.G Chir. 2015 May-Jun;36(3):117-21. G Chir. 2015. PMID: 26188756 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical